EGFR and familial pancreatic carcinoma: Overexpression of EGFR has been implicated in pancreatic carcinoma aggressiveness and resistance to chemo- and radiation therapy.22,23 In a recent study by Morgan et al. 24, EGFR inhibitors cetuximab and erlotinib was used in combination with gemcitabine for enhanced efficacy against pancreatic cancer.